KHAIRUNISSA MOHIUDDIN: Open Payments
NPI 1932661170 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 23 payments from 13 companies in 2025. Trend: 2023 $76 · 2024 $252 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| Amgen Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Medtronic, Inc. | 2 | $39 |
| Dynavax Technologies Corporation | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
Products named: REXULTI, Ozempic, MINIMED 780G, Heplisav-B, NURTEC ODT, REPATHA, SHINGRIX, Rybelsus.
Industry payments across KY — which companies pay providers there.
